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Summary
Objective:  To describe the status of cases 2-3 years after the initiation of treatment under DOTS.
Setting: After DOTS implementation in Tiruvallur district, south India, we followed up a cohort of smear-positive TB
patients registered during 2002-03 after initiation of treatment.
Results: The overall mortality rate was 15.0% and among the remaining 18.6% had active disease. In multivariate analysis,
a higher mortality rate was independently associated with age, sex, occupation, treatment outcome and initial body weight
of patients.
Conclusion: The mortality and morbidity rates are still high during follow-up and needs to be curtailed by addressing these
issues effectively in TB control programme.
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INTRODUCTION
The Directly Observed Treatment- Short
Course (DOTS) strategy, with the objectives of
curing at least 85% new smear-positive cases and
detecting a minimum of 70% of these cases
has been beneficial and successful in reducing
the death rates and increasing the successful
t reatment  outcomes 1 (cure  and t rea tment
completion).  It reduces the chances of default,
failure and relapses and prevents emergence of
multi-drug resistant tuberculosis (MDRTB).
Tuberculosis  Research Centre (TRC) had
monitored the DOTS programme in one TB unit
(TU) of Tiruvallur district, south India for a
period of 5 years since its implementation in
1999 and undertaken different operational
studies and generated valuable data on various
components. We have not looked into the long
term status of cases treated under a DOTS
programme.  This paper describes the status
of  cases  2-3 years  af ter  the ini t ia t ion of
treatment under DOTS in the same area and
describes the ways and means of reducing the
mortality and morbidity.
METHODOLOGY
The study area is semi-urban with a
population of 580,000 having 17 governmental
health care facilities, including 7 designated
microscopy centers for sputum examination.
Subjects attending these health facilities with
a history of chest symptoms or cough for 3
weeks or more were screened for TB by sputum
smear microscopy by Ziehl-Neelsen method2.
Those diagnosed to have TB were categorized,
treated and monitored according to the RNTCP
guidel ines . 3 Smear-posi t ive  TB pat ients
registered for treatment during the year 2002
and 2003 formed the study population. Those
who were in 2002 and declared successfully
treated, defaulted or failed were followed-up
three years after the initiation of treatment and
those registered in 2003 were followed–up after
two years .   Two sputum specimens were
collected from those who were available at the
time of the visit by a health worker at their
residence. These specimens were transported
to the TRC laboratory and processed for smear,
culture and drug susceptibility tests. A patient
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was considered positive if he became (i) smear-
positive on two specimens or (ii) one smear-
positive and culture-positive on either of the
specimens or (iii) one culture or both cultures
positive.
ANALYSIS AND RESULTS
             The data were computerized and
further edited for any discrepancy and missing
information. The Chi-square test was used for
testing the difference in the proportions. Uni-
variate analysis was performed to find the
distribution of factors among patients died
during the follow-up. Odds ratio (OR) and 95%
confidence intervals (95% CI) were calculated.
In multivariate analysis, significant factors
were included to find independent association
of factors with mortality rates adjusting for
confounding factors. Adjusted Odds Ratios
(AOR) were  a lso  obta ined.  Sta t i s t ica l
significance was set at P< 0.05.
A total of 1171 smear-positive cases
were registered for treatment during the period
2002-2003. Of these, 880 were new smear-
positive cases (Category I), 255 previously
treated smear-positive cases (Category II) and
the remaining 36 cases were treated under non-
DOTS regimens. Among the 36 treated under
non-DOTS,  three  were  declared ‘cured’ ,
twenty seven defaulted, four expired, and two
failed.  Fifty-eight patients expired during
treatment period. Thus, there were 1113 cases
eligible for follow-up.  However, 25 cases for
follow-up were missed due to some unavoidable
factors. Of the remaining 1088 cases followed
up, 148 expired, 54 migrated and 46 could not
be traced despite  three at tempts.  Sputum
samples were collected from the remaining 840
cases. The overall mortality rate was 15.0%
(148 of 988; annually 6.1%) and among the
remaining 18.6% (156 of 840) had active
disease. The mortality was 11.3% (87 of 768)
for category I patients compared to 25.7% (53
of 206) for category II patients The overall
mortality was higher among defaulted (42.0%;
74 of 176) and failed (34.4%; 22 of 64) patients
compared to patients who have successfully
completed the treatment (6.0%; 44 of 734).
Category II patients had more active cases
(29.4%; 45 of 153) than Category I patients
(15.7%; 107 of 681) (Table 1).
The risk factors for a higher mortality
among all smear-positive cases followed-up are
shown in Table 2.  In univariate analysis ,
mortali ty was significantly higher among
patients aged > 40 years than among patients
< 40 years (22% vs 8%); Similarly, a higher
proport ion of  mortal i ty was signif icantly
associated with male sex,  unemployment,
smoking, drinking, resistance to isoniazid (H)/
rifampicin (R) and in both RH, previous history
Table 1: Status at follow-up by category and outcome of former treatment outcome of patients
treated under a DOTS programme in a district, south India
 Category I Category II 
Outcome Expired (%) Pos* Neg+ Total Expired (%) Pos Neg Total 
Cured 39(6.0) 75 532 646 5(5.7) 19 64 88 
Defaulted 32(43.8) 14 27 73 42(40.8) 23 38 103 
Failed 16(32.7) 18 15 49 6(40.0) 3 6 15 
Total 87(11.3) 107 574 768 53(25.7) 45 108 206 
* Positive by smear and/or culture, + Negative by smear and culture 
Note: 14 cases put on non-DOTS treatment regimens were excluded  
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of anti-TB treatment, default/failure, non-
convers ion,  f i r s t  ac t ion  a t  government
center  and having body weight  < 40 kg.
In  mul t ivar ia te  analys is ,  a  h igher
mortality rate was independently associated
with  age ,  sex ,  occupat ion,  t rea tment
outcome and weight of patients.
A higher proportion of active disease
was independently associated patient’s former
treatment outcome, resistance and smoking
(data not tabulated).
Table 2: Risk factors for mortality among smear-positive patients 2-3 years after the initiation of
treatment under a DOTS programme in a rural district, south India
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DISCUSSION
The main finding of this study is that among
those smear-positive cases declared successfully
treated, defaulted and failed; after 2-3 years of
initiation of treatment, 15% had died and among the
remaining 19% were bacteriologically positive
excreting TB bacilli in the community. An earlier
study4 from the same area reported a 12% relapse
after a two-year follow-up of cured new smear-
positive patients (category I). The present study
findings were for those cured, defaulted and failed
patients followed up for a period of 2-3 years after
starting the treatment. In the present study also the
relapse rate was estimated to be 12% (75 of 607)
among new smear-positive cases (category I)
declared ‘cured’. When the defaulted and failed cases
were included the proportion of the number of active
cases increased to 16% (107 of 681).  The
corresponding figures for category II cases were
23% (19 of 83) and 29% (45 of 153) respectively
(Table 1).
In a study5 (1988-89) from North Arcot
district in Tamil Nadu during the SCC period before
implementation of DOTS, the overall mortality rate
was reported to be 28% and of the remaining 31%
had active TB (not all patients had SCC). In our study,
we have observed less mortality and active TB. This
is because of an effective and successful TB control
program like DOTS. Still, the mortality and morbidity
rate was high and it is more among default and failure
cases compared to cured, including treatment
completed cases. Among the 148 patients died, we
could not ascertain whether they died with positivity
after treatment or not. The proportion of active cases
would have been much higher had we included these
cases. A study6 on risk factors associated with
default, failure and death, higher death rates were
independently associated with body weight and
previous history of treatment. We can reduce
mortality by preventing the default and returning
defaulters to treatment. It may be noted that the
overall default rate is high (9.5%; 73/768) but has
come down considerably over the time-periods. This
can be achieved by making DOTS more convenient
to patients. Male patients and those above 40 years
should be motivated for regular treatment. For under
weight patients, nutritional supplementation should
be explored. In a recent follow-up study7 in Chennai
city, the mortality rate of patients treated under DOTS
was 60/1000 person years and the excess mortality
rate was six times more than the general population.
A study is warranted to assess whether there is any
primary hidden failures were present at the time of
classifying the patients as completed treatment and
any unconfirmed deaths among the defaulters.
In conclusion, the mortality rate and
those who had active TB was high among smear-
positive cases followed up at 2-3 years after the
initiation of treatment. These rates, still, need
to be reduced by addressing the issues effectively
in TB control programme.
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